Form D · Biotechnology
GlycosBio Inc.
Houston, TX · CIK 0001427515
Offering snapshot reported Mar 21, 2024 · SEC filing
- Reported sold
- $1.13M Offering amount: $5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 6, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2024 | Initial | $1,125,000 | No comparison | 5 | SEC filing |
| Apr 7, 2023 | Initial | $425,000 | No comparison | 3 | SEC filing |
| Jan 4, 2017 | Initial | $829,846 | No comparison | 15 | SEC filing |
| Oct 11, 2013 | Initial | $375,250 | No comparison | 3 | SEC filing |
| Feb 28, 2013 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Oct 20, 2010 | Initial | $4,220,385 | No comparison | 15 | SEC filing |
| Oct 20, 2010 | Initial | $4,220,385 | No comparison | 15 | SEC filing |
| Apr 7, 2009 | Initial | $2,350,000 | No comparison | Not reported | SEC filing |
| Feb 13, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-508267
Source: Form D, filed Mar 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Walter S. Burnap | Director, Executive |
| Paul Campbell | Director, Executive |
| Richard C. Jr. Cilento | Director, Executive |
| Frank Foster | Director |
| Steve Jurvetson | Director |
| Gary Mossman | Director |
| Victoria Niklas | Director |
| John Replogle | Director |
| Joseph Walowski | Director |
| Dan Watkins | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2450 Holcombe Suite J
Houston, TX, 77021
Houston, TX, 77021